In contrast, tumor DCs that are deficient in LRP5/6 or β-catenin expressed markedly higher levels of IL-12, IL-6, IL-23, and TNF-α, and lower levels of immune regulatory factors (21, 22). Here, LRP5 is linked to neoplasm.